Non-interventional surveillance of effectiveness of Symbicort maintenance and reliever therapy (Symbicort SMART [Symbicort Maintenance And Reliever Therapy treatment]) in the treatment of moderate and severe asthma.
Phase of Trial: Phase III
Latest Information Update: 30 Nov 2010
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 22 Jul 2009 Actual patient number (330) added as reported by ClinicalTrials.gov.
- 22 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2009 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.